The estimated Net Worth of B Kristine Johnson is at least 1.29 百万$ dollars as of 14 May 2024. Ms. Johnson owns over 17,153 units of Atricure Inc stock worth over 1,011,601$ and over the last 21 years she sold ATRC stock worth over 83,275$. In addition, she makes 199,978$ as Independent Director at Atricure Inc.
B has made over 12 trades of the Atricure Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 17,153 units of ATRC stock worth 461,416$ on 14 May 2024.
The largest trade she's ever made was selling 79,622 units of Atricure Inc stock on 18 July 2023 worth over 5,574$. On average, B trades about 2,249 units every 85 days since 2004. As of 14 May 2024 she still owns at least 37,606 units of Atricure Inc stock.
You can see the complete history of Ms. Johnson stock trades at the bottom of the page.
B. Kristine Johnson serves as Independent Director of the Company. Ms. Johnson has served as one of our directors since March 2017. Ms. Johnson is President of Affinity Capital Management, a venture capital firm that invests primarily in seed and early-stage health care companies in the United States. She has held this position since 2000. Prior to joining Affinity Capital Management in 1999, Ms. Johnson was Senior Vice President and Chief Administrative Officer of Medtronic, Inc. During her seventeen years at Medtronic, she also served as President and General Manager of its vascular business and President and General Manager of its tachyarrhythmia management business. She currently serves as a director for ClearPoint Neuro, formerly MRI Interventions. She also serves as the board chair of the University of Minnesota Foundation Investment Advisors, as well as serving on the boards of several private entities. She previously served on the Board of Directors of Piper Jaffray, a publicly-held middle market investment bank and asset management firm. Her previous public board experience also includes service on the Boards of Directors of Spectranetics Corporation, which was acquired by Philips, ADC Telecommunications, which was acquired by Tyco Electronics, and Pentair. Ms. Johnson received her B.A. from St. Olaf College.
As the Independent Director of Atricure Inc, the total compensation of B Johnson at Atricure Inc is 199,978$. There are 6 executives at Atricure Inc getting paid more, with Michael Carrel having the highest compensation of 5,829,780$.
B Johnson is 68, she's been the Independent Director of Atricure Inc since 2017. There are 1 older and 11 younger executives at Atricure Inc. The oldest executive at Atricure Inc is Sven Wehrwein, 69, who is the Independent Director.
B's mailing address filed with the SEC is C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD, CO, 80112.
Over the last 19 years, insiders at Atricure Inc have traded over 52,789,242$ worth of Atricure Inc stock and bought 666,621 units worth 5,937,195$ . The most active insiders traders include Scott William Drake、Group I, Llc Donoghue Danie...、Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of 548,410$. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth 84,245$.
atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
Atricure Inc executives and other stock owners filed with the SEC include: